Antimicrobial therapy. Cost-benefit considerations.
Guglielmo
B J
BJ
Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco.
Brooks
G F
GF
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans
D000890:Anti-Infective Agents